2-hydroxycyclopentan-1-one (>90%) - CAS 473-84-7
Catalog: |
BB060872 |
Product Name: |
2-hydroxycyclopentan-1-one (>90%) |
CAS: |
473-84-7 |
Synonyms: |
2-hydroxycyclopentan-1-one; 2-hydroxycyclopentanone; Cyclopentanone, 2-hydroxy-; hydroxycyclopentanone; 2-hydroxy-cyclopentan-1-one |
IUPAC Name: | 2-hydroxycyclopentan-1-one |
Description: | 2-hydroxycyclopentan-1-one (cas# 473-84-7) is a useful research chemical. |
Molecular Weight: | 100.11 |
Molecular Formula: | C5H8O2 |
Canonical SMILES: | C1CC(C(=O)C1)O |
InChI: | InChI=1S/C5H8O2/c6-4-2-1-3-5(4)7/h4,6H,1-3H2 |
InChI Key: | LUTDLYPHDVQSHT-UHFFFAOYSA-N |
Solubility: | Chloroform (Slightly), Methanol (Slightly) |
Appearance: | Clear Colourless Oil |
Storage: | Hygroscopic, Refrigerator, under inert atmosphere |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
AU-2018347460-A1 | Methods for treating diseases associated with ciliopathies | 20171013 |
CA-3078865-A1 | Methods for treating diseases associated with ciliopathies | 20171013 |
WO-2019075369-A1 | METHODS OF TREATING DISEASES ASSOCIATED WITH CILIOPATHIES | 20171013 |
BR-112020007006-A2 | methods for the treatment of diseases associated with ciliopathies | 20171013 |
CN-111447973-A | Methods for treating diseases associated with ciliosis | 20171013 |
EP-3694606-A1 | Methods for treating diseases associated with ciliopathies | 20171013 |
JP-2020536936-A | How to treat diseases related to ciliopathy | 20171013 |
KR-20200070259-A | How to treat diseases associated with ciliosis | 20171013 |
US-2021186985-A1 | Methods for treating diseases associated with ciliopathies | 20171013 |
AU-2018280264-A1 | Compositions and methods for preventing or treating muscle conditions | 20170609 |
PMID | Publication Date | Title | Journal |
21650169 | 20110701 | Concise total synthesis of (±)-cephalotaxine via a transannulation strategy: development of a facile reductive oxy-Nazarov cyclization | Organic letters |
17931866 | 20071201 | Synthesis and evaluation of novel pyrazolidinone analogs of PGE2 as EP2 and EP4 receptors agonists | Bioorganic & medicinal chemistry letters |
17373779 | 20070419 | Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents | Journal of medicinal chemistry |
17784953 | 20070101 | Metabolic peculiarities of Aspergillus niger disclosed by comparative metabolic genomics | Genome biology |
15704938 | 20050217 | Synthetic efforts toward the C22-C36 subunit of halichondrin B utilizing local and imposed symmetry | Organic letters |
12643927 | 20030324 | Discovery of a potent and selective agonist of the prostaglandin EP4 receptor | Bioorganic & medicinal chemistry letters |
12054970 | 20020614 | A new approach to (-)-swainsonine by ruthenium-catalyzed ring rearrangement | The Journal of organic chemistry |
Complexity: | 88.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 100.052429494 |
Formal Charge: | 0 |
Heavy Atom Count: | 7 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 100.052429494 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 37.3Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS